Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor73

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor21

Views

Views
November 20251
December 20255
January 20264
February 20262
March 20266
April 20263
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
United Kingdom4
Brazil1
Canada1
Chile1
Ecuador1
Spain1
Finland1
Mexico1
 

Top cities views

Views
San Jose4
Ashburn2
Charlotte1
Helsinki1
Madrid1
Monterrey1
Osorno1
Quito1
Votorantim1
Welland1